📰 Breaking News: Lessons Learnt & Insights from UK’s first and to date only SME Restructuring Plan

Notices to creditors (MVL)

Surrey and Sussex Surgical Ltd members' voluntary liquidation

active Company no. 11181088 Published 26 October 2026

In short: Surrey and Sussex Surgical Ltd (company no. 11181088) entered members' voluntary liquidation, a solvent and planned closure, according to a Notices to creditors (MVL) notice published in The London Gazette on 26 October 2026. The office holders are John William Butler (IP number 9591); Andrew James Nichols (IP number 8367), appointed 21 October 2026.

The joint liquidators intend to declare a first and final dividend to unsecured creditors of Surrey and Sussex Surgical Ltd and set a deadline of 21 January 2027 for creditors to submit proofs of debt.

Notice details

Company
Surrey and Sussex Surgical Ltd
Company number
11181088
Registered office
The Chapel, Bridge Street, Driffield, YO25 6DA
Notice type
Notices to Creditors
Date of appointment
21 October 2026
Liquidator
John William Butler (IP number 9591); Andrew James Nichols (IP number 8367)

What this notice means

A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.

Read more: What is Liquidation?.

What happens next

Because this is a solvent liquidation, creditors are paid in full. The liquidator advertises for claims, settles them, distributes the surplus to the shareholders and the company is then dissolved. Anyone owed money should still submit their claim to the liquidator named in the notice, and within the period the notice states.

All notices for Surrey and Sussex Surgical Ltd

3 Gazette notices on record for company no. 11181088, newest first. The full history, with last filed accounts, is on the Surrey and Sussex Surgical Ltd company record.

  1. Resolution for winding up (MVL) 26 Oct 2026
  2. Appointment of liquidators (MVL) 26 Oct 2026

How does this notice affect you?

Choose what applies and we'll point you at the right next step.

Related guidance

Free, practical guides from K2 on what this kind of notice means for directors.

More liquidation notices

← Back to all notices

Frequently asked questions

Is Surrey and Sussex Surgical Ltd in financial difficulty?

No — this is a solvent process. A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress. The London Gazette published a Notices to creditors (MVL) for Surrey and Sussex Surgical Ltd (company no. 11181088) on 26 October 2026.

What does a Notices to creditors (MVL) mean?

A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.

What happens next?

Because this is a solvent liquidation, creditors are paid in full. The liquidator advertises for claims, settles them, distributes the surplus to the shareholders and the company is then dissolved. Anyone owed money should still submit their claim to the liquidator named in the notice, and within the period the notice states.

Who is dealing with the liquidation?

The office holders named in the notice: John William Butler (IP number 9591); Andrew James Nichols (IP number 8367), appointed 21 October 2026. Creditors, employees and anyone holding goods or money belonging to the company should contact them directly, quoting the company number.

Source: The London Gazette and Companies House. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright. This page is provided by K2 Partners for information only and is not legal or financial advice.